Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec's University teaching hospitals. - Labrie V; Lefebvre J; Labbé C; Jao K; Malick M; Simard S; Bouchard N (Frontiers in oncology, 2024)